{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:58:48Z","timestamp":1761947928400},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T00:00:00Z","timestamp":1398384000000},"content-version":"vor","delay-in-days":55,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.aprim.2013.09.003","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T05:01:39Z","timestamp":1383714099000},"page":"147-155","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["An\u00e1lisis de la dispensaci\u00f3n de medicamentos para el control de los principales factores de riesgo cardiovascular en la Regi\u00f3n de Murcia: \u00bfexisten diferencias de g\u00e9nero?"],"prefix":"10.1016","volume":"46","author":[{"given":"Diego P.","family":"S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 J.","family":"Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto M.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando I.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2013.09.003_bib0005","unstructured":"INEbase. Instituto Nacional de Estad\u00edstica [consultado 20 Feb 2013]. Disponible en: http:\/\/www.ine.es\/inebmenu\/indice.htm"},{"key":"10.1016\/j.aprim.2013.09.003_bib0010","unstructured":"Cirera Suarez L. Mortalidad regional por causas del a\u00f1o 2010. Bol Epidemiol Murcia. 2012;32:25\u201332."},{"key":"10.1016\/j.aprim.2013.09.003_bib0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1157\/13116658","article-title":"Factores de riesgo cardiovascular. Perspectivas derivadas del Framingham Heart Study","volume":"61","author":"O\u2019Donnell","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.aprim.2013.09.003_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.recesp.2010.11.005","article-title":"Factores de riesgo cardiovascular en Espa\u00f1a en la primera d\u00e9cada del siglo XXI: an\u00e1lisis agrupado con datos individuales de 11 estudios de base poblacional, estudio DARIOS","volume":"64","author":"Grau","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.aprim.2013.09.003_bib0025","unstructured":"Montero D, Garc\u00eda del Pozo J, Abajo FJ de. Utilizaci\u00f3n de antihipertensivos en Espa\u00f1a (1992-2006). Observatorio del uso de medicamentos de la AEMPS. 2006;1 [consultado 20 Feb 2013]. Disponible en: http:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/observatorio\/docs\/antihipertensivos.pdf"},{"key":"10.1016\/j.aprim.2013.09.003_bib0030","unstructured":"Garc\u00eda del Pozo J, Madurga M, Abajo FJ de. Utilizaci\u00f3n de hipolipemiantes en Espa\u00f1a (1992-2006). Observatorio del uso de medicamentos de la AEMPS. 2006;1 [consultado 20 Feb 2013]. Disponible en: http:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/observatorio\/docs\/hipolipemiantes.pdf"},{"key":"10.1016\/j.aprim.2013.09.003_bib0035","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1157\/13126043","article-title":"Prevalencia, distribuci\u00f3n y variabilidad geogr\u00e1fica de los principales factores de riesgo cardiovascular en Espa\u00f1a An\u00e1lisis agrupado de datos individuales de estudios epidemiol\u00f3gicos poblacionales: estudio ERICE","volume":"61","author":"Gabriel","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.aprim.2013.09.003_bib0040","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1445-5994.2011.02534.x","article-title":"Suboptimal management of cardiovascular risk factors in coronary heart disease patients in primary care occurs particularly in women","volume":"41","author":"Driscoll","year":"2011","journal-title":"Intern Med J"},{"key":"10.1016\/j.aprim.2013.09.003_bib0045","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1136\/bmj.e4535","article-title":"Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands UK: cross sectional study","volume":"345","author":"Sheppard","year":"2012","journal-title":"BMJ"},{"issue":"Suppl 8:55","key":"10.1016\/j.aprim.2013.09.003_bib0050","first-page":"58D","article-title":"Proyecto de estudio sobre la situaci\u00f3n de la enfermedad cardiovascular de la mujer en Espa\u00f1a: conclusiones y recomendaciones finales","volume":"10","author":"Anguita","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.aprim.2013.09.003_bib0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2013.09.003_bib0060","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1097\/HJH.0b013e328339f9c5","article-title":"Treatment of hypertension in patients 80 years and older: the lower the better?. A meta-analysis of randomized controlled trials","volume":"28","author":"Bejan-Angoulvant","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.aprim.2013.09.003_bib0065","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aprim.2013.09.003_bib0070","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1097\/00004872-200312000-00030","article-title":"Results of the pilot study for the hypertension in the very elderly trial","volume":"21","author":"Bulpitt","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.aprim.2013.09.003_bib0075","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2165\/11318270-000000000-00000","article-title":"Lipid-lowering therapy for the primary prevention of cardiovascular disease in the elderly: Opportunities and challenges","volume":"26","author":"Robinson","year":"2009","journal-title":"Drugs & Aging"},{"key":"10.1016\/j.aprim.2013.09.003_bib0080","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2013.09.003_bib0085","series-title":"Clinical Guidelines and Evidence Review for Lipid Modification: Cardiovascular risk asses- sment and the primary and secondary prevention of cardiovascular disease","author":"Cooper","year":"2008"},{"key":"10.1016\/j.aprim.2013.09.003_bib0090","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-152-8-201004200-00005","article-title":"Rosuvastatin for primary prevention in older persons with elevated c-reactive protein and low to average low-density lipoprotein cholesterol levels: Exploratory analysis of a randomized trial","volume":"152","author":"Glynn","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aprim.2013.09.003_bib0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1157\/13115104","article-title":"Gender influence in the quantity of drugs used in primary care","volume":"22","author":"Sanf\u00e9lix","year":"2008","journal-title":"Gac Sanit"},{"key":"10.1016\/j.aprim.2013.09.003_bib0100","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2125.2007.03029.x","article-title":"Identifying how age and gender influence prescription drug use in a primary health care environment in Catalonia","volume":"65","author":"Fern\u00e1ndez-Liz","year":"2008","journal-title":"Spain Br J Clin Pharmacol"},{"key":"10.1016\/j.aprim.2013.09.003_bib0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2458-6-155","article-title":"Gender differences in the utilization of health-care services among the older adult population of Spain","volume":"6","author":"Redondo-Sendino","year":"2006","journal-title":"BMC Public Health"},{"key":"10.1016\/j.aprim.2013.09.003_bib0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0213-9111(02)71643-9","article-title":"Prevalencia del consumo de medicamentos en la poblaci\u00f3n adulta de Catalu\u00f1a","volume":"16","author":"Sans","year":"2002","journal-title":"Gac Sanit"},{"key":"10.1016\/j.aprim.2013.09.003_bib0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.rce.2011.10.011","article-title":"La enfermedad cardiovascular en funci\u00f3n del g\u00e9nero: mitos y evidencias","volume":"212","author":"Coca","year":"2012","journal-title":"Rev Clin Esp"},{"issue":"Supl 8:","key":"10.1016\/j.aprim.2013.09.003_bib0120","first-page":"37D","article-title":"Hipertensi\u00f3n arterial en la mujer en Espa\u00f1a: an\u00e1lisis de los registros de la Secci\u00f3n de Hipertensi\u00f3n Arterial de la Sociedad Espa\u00f1ola de Cardiolog\u00eda","volume":"30","author":"Maz\u00f3n","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.aprim.2013.09.003_bib0125","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.recesp.2011.04.018","article-title":"Control de la presi\u00f3n arterial en las mujeres hipertensas de 65 o m\u00e1s a\u00f1os de edad asistidas en atenci\u00f3n primaria Estudio MERICAP","volume":"64","author":"Llisterri Caro","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.aprim.2013.09.003_bib0130","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0300-8932(09)72100-1","article-title":"Colesterol HDL y enfermedad cardiovascular en mujeres hipertensas de Espa\u00f1a. Estudio RIMHA","volume":"62","author":"Coca","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.aprim.2013.09.003_bib0135","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJM198909073211004","article-title":"Menopause and risk factors for coronary heart disease","volume":"321","author":"Matthews","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aprim.2013.09.003_bib0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy-I:Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2013.09.003_bib0145","first-page":"45","article-title":"Incidencia y letalidad por infarto agudo de miocardio en la Regi\u00f3n de Murcia 1997-98: Estudio IBERICA Murcia","volume":"23","author":"Tormo","year":"2002","journal-title":"Bol Epidemiol Murcia"},{"issue":"Supl.1","key":"10.1016\/j.aprim.2013.09.003_bib0150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1157\/13062260","article-title":"Sesgo de g\u00e9nero en el esfuerzo terap\u00e9utico","volume":"18","author":"Ruiz-Cantero","year":"2004","journal-title":"Gac Sanit"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656713002473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656713002473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T21:23:47Z","timestamp":1539206627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656713002473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0212656713002473"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2013.09.003","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An\u00e1lisis de la dispensaci\u00f3n de medicamentos para el control de los principales factores de riesgo cardiovascular en la Regi\u00f3n de Murcia: \u00bfexisten diferencias de g\u00e9nero?","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2013.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}